GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

BOLT · Sep 30, 2024

Bolt Biotherapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000950170-24-125413General Corporate
Capex intensity56thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

3.59% · OPTIONAL · VALID

Operating cash generation44thOwn-history percentile · N=9
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-1224.01% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-54.87% · CORE · NOT_ENOUGH_HISTORY

Operating margin33thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.operating_margin

-1441.10% · CORE · VALID

R&D intensity67thOwn-history percentile · N=9
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

1208.15% · OPTIONAL · VALID

SBC intensity22thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

96.23% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.00%
Current
3.59%
Delta
3.59%
Cash Generation Increased
Previous
-1266.04%
Current
-1224.01%
Delta
42.03%
Growth Decreased
Previous
-11.03%
Current
-54.87%
Delta
-43.84%
Profitability Increased
Previous
-1772.31%
Current
-1441.10%
Delta
331.21%
R And D Intensity Decreased
Previous
1210.43%
Current
1208.15%
Delta
-2.28%
Sbc Intensity Decreased
Previous
221.57%
Current
96.23%
Delta
-125.34%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.